Development, Characterization, and in vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer. - Diorio AM; Daram A; Sriram N; Lund T; Watts AB; Kunda NK (AAPS PharmSciTech, 2025)